A manifestation of severe sarcoid arthropathy in the distal interphalangeal joint by Ark, Rajiv
The patient has had several episodes of psychosis and confusion which
were previously diagnosed as schizophrenia and corticosteroid induced
psychosis, meaning the team used steroids cautiously. MRI brain imag-
ing revealed the presence of extensive neurosarcoidosis, and the neuro-
cognitive improvement with treatment of a TNF inhibitor, suggested that
the underlying pathology was sarcoidosis. Steroids could therefore be
utilised appropriately for ongoing management. This case illustrates the
difficulty of teasing out the underlying aetiology of neurocognitive dys-
function inpatientswithextensivesarcoidosis.
TNFa released by alveolar macrophages is implicated in the induction
and maintenance of sarcoid granulomas. Limited data from small rando-
misedcontrolled trialsand increasingdata fromnon-randomisedstudies
have led to consensus-based recommendations for TNFi use in pulmo-
nary, ocular, cutaneous, neurological, and multi-system sarcoidosis. To
ourknowledge, thiscase is the firstdocumentedexampleof rapidclinical
andradiological resolutionofsarcoidmyositiswithananti-TNFagent.
Case report - Key learning points: There are three important points to
takeawayfromthiscase.
First, this case highlights the importance of a PET scan in demonstrating
multi-system involvement in sarcoidosis. The PET scan was key in high-
lighting theextentofdisease includingsarcoid myositis.MRIscansof the
brain were also important in highlighting the extent of neurosarcoidosis.
Second,thepatientpresentedwithpsychosisin2013.Thiswasthoughttobe
corticosteroid-induced at the time. However, since treatment with the TNF
inhibitor the patient experienced a significant neurocognitive improvement.
Thedrasticimprovementunderminesthediagnosisofprimarypsychosisand
suggests that the psychosis may have been due to neurosarcoidosis. In the
context of patients with multi-organ sarcoidosis, psychosis secondary to
neurosarcoidshouldbeconsideredasadifferential,even in thecontextofan
earlierdiagnosisofschizophreniapre-datingthediagnosisofsarcoid.
Third, the drastic resolution of sarcoid myositis and arthritis with a TNF
inhibitor suggests that TNF inhibitors should be considered as treatment
for cases of sarcoid myositis or sarcoid arthritis refractory to steroids.
Whilst TNF inhibitors are currently unlicensed for this use in the UK, there
is a growing body of evidence for their effectiveness in treating refractory
extra-pulmonarysarcoidosis.
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Case report - Introduction: In 2011 a gentleman in his 50s presented
with nasal blockage and bloody discharge. He was diagnosed with sar-
coidosis and after 9 years of failed strategies to control his disease, he
developeddactylitis.X-rayof thehandsshowedseverearthropathyinthe
distal interphalangeal joints. This case demonstrates an uncommon
extrapulmonarymanifestationofsarcoidosis.Althoughmostofhis follow
up was witha respiratory clinic, hismain symptoms were not due to inter-
stitial lung disease, highlighting the importance of a multidisciplinary
approach. To reduce the need for steroids, several DMARDs were tried
illustratingthattherearelimitedtreatmentoptions.
Casereport-Casedescription:ThisgentlemanpresentedinJune2011




A biopsy was performed, and histology showed a nasal sarcoid granu-
loma.Hewasreferredtotherespiratoryteamwhorequestedahigh-reso-
lution CT scan showing sizeable lymph nodes. One inguinal node was
biopsied confirming sarcoid granulomas before starting treatment.
Calciumwasbrieflyraised,andserumACEwasinitially123.
He was started on 40mg of prednisolone for 6 weeks, which was tapered
to 20/25mg on alternating days. There was a recurrence of his nasal dis-
charge; steroids were increased again but he developed symptoms of
muscleweakness from long termsteroid use.He was referred toan inter-
stitial lung disease clinic ata tertiary centre wherehewas investigated for
cardiac sarcoidosis with MRI due to ventricular ectopics.
Hydroxychloroquine was started to reduce the steroid use however he
developed symptoms of tinnitus, so it was stopped. Methotrexate,
Azathioprine and Leflunomide were all trialled to however they did not
have any impact on controlling his disease. His Prednisolone was slowly
reduced by 1mg a month. When he had recurrence of his symptoms, he
wasgivenIVmethylprednisolone.
Nine years after his first presentation he presented with stiffness of the
right thumb base. This progressed to dactylitis and slight fixed flexion
deformityofright indexfingerandleft little finger.
An x-ray of his hands showed disease in the distal interphalangeal joints
bilaterally with severe changes in the left little finger. The effects of long-
termsteroids ledhimtorequestalettertosupportearlyretirement.
Case report - Discussion: The main rationale for changing treatment
options was to reduce the prednisolone dose. Steroids were the only
treatment option that showed evidence of controlling his disease when
the dose was between 25mg and 40mg a day. Each of the DMARDs that
were trialled had a different side effect profile and did not show any evi-
dence of suppressing disease as symptoms recurred. Dose changes
later in treatment fluctuated, reflecting a balancing act between disease
recurrenceandsideeffectsof long-termsteroids.
There are many extra pulmonary manifestations of sarcoidosis that were
investigated in this case. The first being the nasal granuloma, which can
occur in sarcoid patients with symptoms of epistaxis, crusting, conges-
tion,andpain.
Thereweregranulomatouschangesseeninthehilaaswellasother lymph
nodes such as the inguinal region; inguinal lymphadenopathycan lead to
pain inthegroinarea.
In addition to this it was important to exclude uveitis with ophthalmology
reviewashehadsymptomsofepiphora.Uveitiscanbediagnosedinoph-
thalmological assessment of sarcoid patients in the absence of ocular
complaints.
Cardiac sarcoidosis was excluded with an MRI at a specialist heart and
lung centre due to ventricular ectopics. Cardiac sarcoidosis can lead to
heartblock,arrhythmias,andcongestivecardiacfailure.
Finally, he developed sarcoid arthropathy, review of his radiological
imagesovertimeshowedextensivedamagetothejointsof thehand.
This gentleman had poor outcomes due to limited treatment options for
hisdisease.Being restricted to long termsteroid as the mainstay of treat-
ment led to early retirement due to fatigue and muscle weakness.
Conversely, under dosing steroids led to recurrence in symptoms. His
disease is still not controlled as shown by an evolving sarcoid
arthropathy.
Case report - Key learning points: An illustrationof sarcoid arthropathy
isalso shown in this case. Sarcoid arthropathy is anuncommonmanifes-
tation of the disease primarily affecting joints in the hands and feet. In this
case the distal interphalangeal joints and proximal interphalangeal joints
were affected. The first symptomof arthropathy was stiffness of the base
of the right thumb in 2017, this could fit with an osteoarthritic picture and
couldbemistakenfor it inundiagnosedsarcoidosis.Themostseveredis-
easewas in theDIPof the left little finger,which isnotcommonlyaffected.
Anoligoarthriticpatternwith involvementoftheankle isseenmoreoften.
This is also an unusual case of sarcoidosis as there was no family history
of the disease and his ethnicity did not predispose him to the condition.
He also had a few uncommon extra pulmonary manifestations of
sarcoidosis.




aging hisdisease.Although pulmonary lymph nodeswere enlarged, they
didnotaffecthis lungfunction.
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Case report - Introduction: Sarcoidosis is a multisystem disorder of
unknown aetiology that is characterised pathologically by the presence
of non-caseating granulomata. The disease is known for its multitude of
presentations and can affect almost any organ system. Symptomatic
skeletal muscle involvement in sarcoidosis is infrequent and occurs
in< 3% of all sarcoidosis patients. We present the case of a 47-year-old
male with multisystem sarcoidosis involving his lungs, eyes, and liver,
who presented to our tertiary sarcoid centre with proximal muscle weak-
ness.Thiscase issignificantas ithighlightsthediagnosticchallengesthat
can arise when muscle weakness occurs on a background of
sarcoidosis.
Case report - Case description: A 47-year-old gentleman presented to
Rheumatology with a ten-year history of progressive lower extremity
muscle weakness. He was known to have multisystem sarcoidosis
affecting his lungs (diffuse interstitial lung disease), eyes (anterior uveitis)
and liver (liver fibrosis). His sarcoidosis was initially diagnosed ten years
beforehand, from confirmatory histology obtained via Endobronchial
Ultrasoundsampling.
He was previously a keen runner; however, he had observed a gradual
decline in his ability to run. Over a period of two years his mobility further
deteriorated,andherequiredtwostickstowalk.
Physicalexamination revealedawaddlinggaitwithwasting tohisquadri-
ceps bilaterally. He had reduced power of 2/5 on hip flexion on the
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